Design, synthesis and evaluation of novel selective inhibitors of FAK and IGF-1R function in cancer.
Targeted, image guided release of combinatorial FAK inhibitors in pancreatic cancer.
Novel agents that target FAK and IGF-1R protein interactions.
FAK and IGF-1R interactions in pancreatic cancer survival.
Nanoparticle directed therapy for GI malignancy.
Technical advances in minimally invasive esophagectomy and minimally invasive gastr.ectomy
Outcomes for patients undergoing surgical therapy for upper gastrointestinal cancers.